FONAR Corporation (FONR)
USD 13.49
(-2.25%)
USD 13.49
(-2.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 10.56 Million USD | 12.71% |
| 2023 | 9.37 Million USD | -45.6% |
| 2022 | 17.23 Million USD | 26.04% |
| 2021 | 13.67 Million USD | 16.82% |
| 2020 | 11.7 Million USD | -42.94% |
| 2019 | 20.51 Million USD | -3.38% |
| 2018 | 21.23 Million USD | 8.21% |
| 2017 | 19.62 Million USD | 24.78% |
| 2016 | 15.72 Million USD | 21.8% |
| 2015 | 12.91 Million USD | 24.19% |
| 2014 | 10.39 Million USD | 19.79% |
| 2013 | 8.67 Million USD | 50.24% |
| 2012 | 5.77 Million USD | 82.75% |
| 2011 | 3.16 Million USD | 204.92% |
| 2010 | -3.01 Million USD | -368.69% |
| 2009 | 1.12 Million USD | 108.3% |
| 2008 | -13.5 Million USD | 47.11% |
| 2007 | -25.53 Million USD | 14.77% |
| 2006 | -29.96 Million USD | -3053.77% |
| 2005 | 1.01 Million USD | 110.68% |
| 2004 | -9.49 Million USD | 36.73% |
| 2003 | -15 Million USD | 34.42% |
| 2002 | -22.88 Million USD | -50.7% |
| 2001 | -15.18 Million USD | -38.59% |
| 2000 | -10.95 Million USD | 22.85% |
| 1999 | -14.2 Million USD | -149.12% |
| 1998 | -5.7 Million USD | -110.16% |
| 1997 | 56.1 Million USD | 1750.0% |
| 1996 | -3.4 Million USD | -88.89% |
| 1995 | -1.8 Million USD | -500.0% |
| 1994 | -300 Thousand USD | -250.0% |
| 1993 | 200 Thousand USD | -66.67% |
| 1992 | 600 Thousand USD | -82.86% |
| 1991 | 3.5 Million USD | -28.57% |
| 1990 | 4.9 Million USD | 140.5% |
| 1989 | -12.1 Million USD | -856.25% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 1.87 Million USD | -50.2% |
| 2024 Q2 | 3.75 Million USD | -56.79% |
| 2024 Q1 | 8.7 Million USD | 603.44% |
| 2024 Q4 | 830.39 Thousand USD | -55.64% |
| 2023 Q4 | 1.23 Million USD | -67.96% |
| 2023 FY | 9.37 Million USD | -45.6% |
| 2023 Q1 | 1.92 Million USD | -47.36% |
| 2023 Q2 | 2.23 Million USD | 16.07% |
| 2023 Q3 | 3.86 Million USD | 72.94% |
| 2022 FY | 17.23 Million USD | 26.04% |
| 2022 Q1 | 3.65 Million USD | 439.33% |
| 2022 Q4 | 3.65 Million USD | 12.0% |
| 2022 Q3 | 3.26 Million USD | -13.64% |
| 2022 Q2 | 3.77 Million USD | 3.42% |
| 2021 Q3 | 3.63 Million USD | 24.32% |
| 2021 FY | 13.67 Million USD | 16.82% |
| 2021 Q1 | 2.35 Million USD | 328.07% |
| 2021 Q2 | 2.92 Million USD | 24.12% |
| 2021 Q4 | 677.13 Thousand USD | -81.37% |
| 2020 Q4 | 550.15 Thousand USD | -53.53% |
| 2020 FY | 11.7 Million USD | -42.94% |
| 2020 Q1 | 3.09 Million USD | -32.43% |
| 2020 Q2 | 2.91 Million USD | -5.91% |
| 2020 Q3 | 1.18 Million USD | -59.37% |
| 2019 FY | 20.51 Million USD | -3.38% |
| 2019 Q1 | 3.16 Million USD | -72.15% |
| 2019 Q3 | 3.68 Million USD | 8.74% |
| 2019 Q4 | 4.58 Million USD | 24.41% |
| 2019 Q2 | 3.38 Million USD | 7.05% |
| 2018 Q3 | 3.31 Million USD | -16.9% |
| 2018 Q2 | 3.99 Million USD | 12.64% |
| 2018 FY | 21.23 Million USD | 8.21% |
| 2018 Q4 | 11.36 Million USD | 242.55% |
| 2018 Q1 | 3.54 Million USD | -37.14% |
| 2017 Q4 | 5.63 Million USD | 0.34% |
| 2017 FY | 19.62 Million USD | 24.78% |
| 2017 Q1 | 3.4 Million USD | -43.84% |
| 2017 Q2 | 4.04 Million USD | 18.79% |
| 2017 Q3 | 5.62 Million USD | 39.13% |
| 2016 Q3 | 2.86 Million USD | -13.96% |
| 2016 Q4 | 6.05 Million USD | 111.75% |
| 2016 Q1 | 2.72 Million USD | -49.79% |
| 2016 Q2 | 3.32 Million USD | 22.07% |
| 2016 FY | 15.72 Million USD | 21.8% |
| 2015 Q3 | 1.92 Million USD | -24.04% |
| 2015 Q4 | 5.42 Million USD | 182.32% |
| 2015 FY | 12.91 Million USD | 24.19% |
| 2015 Q2 | 2.52 Million USD | 4.85% |
| 2015 Q1 | 2.41 Million USD | -37.84% |
| 2014 FY | 10.39 Million USD | 19.79% |
| 2014 Q1 | 2.31 Million USD | -49.24% |
| 2014 Q2 | 2.03 Million USD | -12.04% |
| 2014 Q3 | 1.65 Million USD | -18.88% |
| 2014 Q4 | 3.88 Million USD | 134.6% |
| 2013 Q1 | 1.28 Million USD | -4.34% |
| 2013 Q4 | 4.56 Million USD | 346.42% |
| 2013 Q3 | 1.02 Million USD | -20.2% |
| 2013 Q2 | 1.28 Million USD | -0.08% |
| 2013 FY | 8.67 Million USD | 50.24% |
| 2012 Q3 | 1.14 Million USD | -21.67% |
| 2012 Q2 | 1.45 Million USD | 3.55% |
| 2012 Q1 | 1.4 Million USD | 515.09% |
| 2012 FY | 5.77 Million USD | 82.75% |
| 2012 Q4 | 1.34 Million USD | 17.44% |
| 2011 Q3 | 1.01 Million USD | -19.59% |
| 2011 Q4 | 228.91 Thousand USD | -77.43% |
| 2011 Q2 | 1.26 Million USD | 247.38% |
| 2011 FY | 3.16 Million USD | 204.92% |
| 2011 Q1 | 363 Thousand USD | 1140.69% |
| 2010 Q2 | -1.29 Million USD | 25.79% |
| 2010 Q1 | -1.74 Million USD | -3159.86% |
| 2010 FY | -3.01 Million USD | -368.69% |
| 2010 Q4 | 29.25 Thousand USD | 465.73% |
| 2010 Q3 | -8000.00 USD | 99.38% |
| 2009 Q4 | 56.89 Thousand USD | -91.71% |
| 2009 Q2 | 781 Thousand USD | 273.56% |
| 2009 Q3 | 686 Thousand USD | -12.16% |
| 2009 Q1 | -450 Thousand USD | 93.35% |
| 2009 FY | 1.12 Million USD | 108.3% |
| 2008 Q4 | -6.76 Million USD | -151.07% |
| 2008 FY | -13.5 Million USD | 47.11% |
| 2008 Q2 | -3.83 Million USD | -1736.36% |
| 2008 Q1 | -209 Thousand USD | 97.56% |
| 2008 Q3 | -2.69 Million USD | 29.78% |
| 2007 FY | -25.53 Million USD | 14.77% |
| 2007 Q4 | -8.56 Million USD | -58.54% |
| 2007 Q3 | -5.4 Million USD | 1.26% |
| 2007 Q2 | -5.47 Million USD | 10.4% |
| 2007 Q1 | -6.1 Million USD | 31.65% |
| 2006 FY | -29.96 Million USD | -3053.77% |
| 2006 Q4 | -8.93 Million USD | -21.41% |
| 2006 Q3 | -7.35 Million USD | -37.31% |
| 2006 Q2 | -5.35 Million USD | 35.58% |
| 2006 Q1 | -8.31 Million USD | -1822.6% |
| 2005 Q2 | 1.14 Million USD | 45.17% |
| 2005 FY | 1.01 Million USD | 110.68% |
| 2005 Q4 | -432.59 Thousand USD | 9.88% |
| 2005 Q1 | 786 Thousand USD | 151.13% |
| 2005 Q3 | -480 Thousand USD | -142.07% |
| 2004 Q4 | -1.53 Million USD | -3.6% |
| 2004 Q1 | -3.84 Million USD | -25.82% |
| 2004 Q2 | -2.63 Million USD | 31.56% |
| 2004 Q3 | -1.48 Million USD | 43.57% |
| 2004 FY | -9.49 Million USD | 36.73% |
| 2003 Q4 | -3.05 Million USD | 51.72% |
| 2003 FY | -15 Million USD | 34.42% |
| 2003 Q2 | -2.92 Million USD | -7.95% |
| 2003 Q3 | -6.32 Million USD | -116.57% |
| 2003 Q1 | -2.7 Million USD | 70.83% |
| 2002 Q2 | -4.71 Million USD | -22.43% |
| 2002 FY | -22.88 Million USD | -50.7% |
| 2002 Q4 | -9.27 Million USD | -83.67% |
| 2002 Q3 | -5.05 Million USD | -7.22% |
| 2002 Q1 | -3.84 Million USD | 29.58% |
| 2001 FY | -15.18 Million USD | -38.59% |
| 2001 Q1 | -3.9 Million USD | -296.65% |
| 2001 Q4 | -5.46 Million USD | -95.03% |
| 2001 Q3 | -2.8 Million USD | 7.07% |
| 2001 Q2 | -3.01 Million USD | 22.86% |
| 2000 Q3 | -3.96 Million USD | -46.78% |
| 2000 Q4 | -984.98 Thousand USD | 75.15% |
| 2000 FY | -10.95 Million USD | 22.85% |
| 2000 Q1 | -3.3 Million USD | 28.26% |
| 2000 Q2 | -2.7 Million USD | 18.18% |
| 1999 Q2 | -2.5 Million USD | 10.71% |
| 1999 Q3 | -4.3 Million USD | -72.0% |
| 1999 Q4 | -4.6 Million USD | -6.98% |
| 1999 Q1 | -2.8 Million USD | -221.74% |
| 1999 FY | -14.2 Million USD | -149.12% |
| 1998 FY | -5.7 Million USD | -110.16% |
| 1998 Q4 | 2.3 Million USD | 162.16% |
| 1998 Q2 | -2.1 Million USD | 8.7% |
| 1998 Q3 | -3.7 Million USD | -76.19% |
| 1998 Q1 | -2.3 Million USD | -104.13% |
| 1997 Q3 | -4 Million USD | -162.5% |
| 1997 Q1 | -2 Million USD | 50.0% |
| 1997 FY | 56.1 Million USD | 1750.0% |
| 1997 Q4 | 55.7 Million USD | 1492.5% |
| 1997 Q2 | 6.4 Million USD | 420.0% |
| 1996 Q2 | -900 Thousand USD | -125.0% |
| 1996 Q4 | -4 Million USD | -310.53% |
| 1996 FY | -3.4 Million USD | -88.89% |
| 1996 Q1 | -400 Thousand USD | 50.0% |
| 1996 Q3 | 1.9 Million USD | 311.11% |
| 1995 Q2 | -100 Thousand USD | 0.0% |
| 1995 FY | -1.8 Million USD | -500.0% |
| 1995 Q1 | -100 Thousand USD | 80.0% |
| 1995 Q4 | -800 Thousand USD | 11.11% |
| 1995 Q3 | -900 Thousand USD | -800.0% |
| 1994 Q4 | -500 Thousand USD | -600.0% |
| 1994 FY | -300 Thousand USD | -250.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q2 | 100 Thousand USD | 0.0% |
| 1994 Q1 | 100 Thousand USD | 111.11% |
| 1993 FY | 200 Thousand USD | -66.67% |
| 1993 Q4 | -900 Thousand USD | -400.0% |
| 1993 Q2 | 400 Thousand USD | 0.0% |
| 1993 Q3 | 300 Thousand USD | -25.0% |
| 1993 Q1 | 400 Thousand USD | 144.44% |
| 1992 FY | 600 Thousand USD | -82.86% |
| 1992 Q1 | 600 Thousand USD | 0.0% |
| 1992 Q2 | - USD | -100.0% |
| 1992 Q3 | 400 Thousand USD | 0.0% |
| 1992 Q4 | -900 Thousand USD | -325.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | 3.5 Million USD | -28.57% |
| 1991 Q3 | - USD | 0.0% |
| 1990 FY | 4.9 Million USD | 140.5% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 FY | -12.1 Million USD | -856.25% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 117.15% |
| BrainsWay Ltd. | -4.19 Million USD | 351.785% |
| Cerus Corporation | -37.48 Million USD | 128.188% |
| Envoy Medical, Inc. | -29.9 Million USD | 135.333% |
| electroCore, Inc. | -18.83 Million USD | 156.108% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 219.406% |
| IceCure Medical Ltd | -14.65 Million USD | 172.123% |
| Inogen, Inc. | -102.44 Million USD | 110.315% |
| OrthoPediatrics Corp. | -20.97 Million USD | 150.383% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 120.065% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 176.881% |
| MaxCyte, Inc. | -37.92 Million USD | 127.865% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 189.105% |
| Nexalin Technology, Inc. | -4.64 Million USD | 327.319% |
| Orthofix Medical Inc. | -151.39 Million USD | 106.98% |
| PAVmed Inc | -64.17 Million USD | 116.467% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 120.141% |
| RxSight, Inc. | -48.6 Million USD | 121.74% |
| Sight Sciences, Inc. | -55.54 Million USD | 119.024% |
| SI-BONE, Inc. | -43.33 Million USD | 124.385% |
| TELA Bio, Inc. | -46.66 Million USD | 122.646% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 121.337% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 177.799% |
| Acutus Medical, Inc. | -81.66 Million USD | 112.94% |
| Talis Biomedical Corporation | -62 Million USD | 117.042% |
| Spectral AI, Inc. | -20.85 Million USD | 150.673% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 117.387% |
| CVRx, Inc. | -41.19 Million USD | 125.65% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -1550.65% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 196.459% |
| Bioventus Inc. | -156.23 Million USD | 106.764% |
| Venus Concept Inc. | -37.25 Million USD | 128.369% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 117.899% |
| LivaNova PLC | 17.54 Million USD | 39.773% |
| 908 Devices Inc. | -36.39 Million USD | 129.032% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 105.662% |
| Nemaura Medical Inc. | -14.14 Million USD | 174.714% |
| NeuroPace, Inc. | -32.95 Million USD | 132.065% |
| LENSAR, Inc. | -14.38 Million USD | 173.471% |
| Apyx Medical Corporation | -18.71 Million USD | 156.471% |
| Cutera, Inc. | -162.83 Million USD | 106.49% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 197.575% |
| BioSig Technologies, Inc. | -29.04 Million USD | 136.388% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 112.783% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 147.84% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 84.4% |
| Axonics, Inc. | -6.08 Million USD | 273.577% |
| Outset Medical, Inc. | -172.79 Million USD | 106.115% |
| IRIDEX Corporation | -9.57 Million USD | 210.422% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 109.979% |
| IRadimed Corporation | 17.19 Million USD | 38.536% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 228.183% |
| INVO Bioscience, Inc. | -8.03 Million USD | 231.523% |
| Telesis Bio, Inc. | -47.72 Million USD | 122.143% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -3.167% |
| Varex Imaging Corporation | -47.7 Million USD | 122.154% |
| Quipt Home Medical Corp. | -2.78 Million USD | 479.576% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 193.633% |
| Pulmonx Corporation | -60.84 Million USD | 117.368% |
| Dynatronics Corporation | -2.69 Million USD | 491.716% |
| Modular Medical, Inc. | -17.47 Million USD | 160.489% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 192.802% |
| Semler Scientific, Inc. | 20.58 Million USD | 48.66% |
| InMode Ltd. | 197.91 Million USD | 94.661% |
| Bruker Corporation | 427.2 Million USD | 97.526% |
| Cytosorbents Corporation | -28.5 Million USD | 137.069% |
| DexCom, Inc. | 541.5 Million USD | 98.048% |
| Align Technology, Inc. | 445.05 Million USD | 97.626% |
| Viveve Medical, Inc. | -22.02 Million USD | 147.975% |
| ZimVie Inc. | -393.28 Million USD | 102.687% |
| Movano Inc. | -29.28 Million USD | 136.087% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 186.989% |
| Nexalin Technology, Inc. | -4.64 Million USD | 327.319% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -1550.65% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 104.747% |
| Profound Medical Corp. | -28.56 Million USD | 136.989% |
| Insulet Corporation | 206.3 Million USD | 94.878% |
| enVVeno Medical Corporation | -23.51 Million USD | 144.937% |
| Surmodics, Inc. | -11.54 Million USD | 191.556% |
| iCAD, Inc. | -4.84 Million USD | 318.019% |
| Nuwellis, Inc. | -20.2 Million USD | 152.291% |
| Biotricity, Inc. | -14.09 Million USD | 174.976% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 108.563% |
| Aethlon Medical, Inc. | -12.2 Million USD | 186.56% |
| InspireMD, Inc. | -19.91 Million USD | 153.06% |
| PAVmed Inc. | -64.17 Million USD | 116.467% |
| BIOLASE, Inc. | -20.63 Million USD | 151.218% |
| Beyond Air, Inc. | -60.24 Million USD | 117.542% |
| AxoGen, Inc. | -21.71 Million USD | 148.662% |
| Vivani Medical, Inc. | -25.65 Million USD | 141.195% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 62.941% |
| Inari Medical, Inc. | -1.63 Million USD | 745.929% |
| UFP Technologies, Inc. | 44.92 Million USD | 76.477% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 305.899% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 259.986% |
| Tenon Medical, Inc. | -15.58 Million USD | 167.822% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 168.504% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 129.908% |
| AdaptHealth Corp. | -678.89 Million USD | 101.557% |
| Sintx Technologies, Inc. | -8.25 Million USD | 227.95% |
| NanoVibronix, Inc. | -3.71 Million USD | 384.759% |
| Quanterix Corporation | -32.33 Million USD | 132.682% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 193.633% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -2078.845% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 103.445% |
| TransMedics Group, Inc. | -25.02 Million USD | 142.222% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 147.745% |
| NeuroMetrix, Inc. | -6.52 Million USD | 261.841% |
| Hyperfine, Inc. | -44.23 Million USD | 123.888% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 113.461% |
| Biomerica, Inc. | -5.97 Million USD | 276.771% |
| Bone Biologics Corporation | -8.94 Million USD | 218.088% |
| AVITA Medical, Inc. | -39.16 Million USD | 126.98% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 206.164% |
| Silk Road Medical, Inc | -55.74 Million USD | 118.957% |